JENNIFER RICHARDSON: Open Payments
NPI 1699767384 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 92 payments from 22 companies in 2025. Trend: 2023 $1,137 · 2024 $1,429 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $210 |
| ABBVIE INC. | 15 | $206 |
| Novo Nordisk Inc | 16 | $196 |
| AstraZeneca Pharmaceuticals LP | 3 | $144 |
| Amgen Inc. | 16 | $139 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Astellas Pharma US Inc | 2 | $58 |
| Lilly USA, LLC | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
Products named: NURTEC ODT, QULIPTA, FARXIGA, Wegovy, EVENITY, TRELEGY ELLIPTA, Veozah, Ozempic.
Industry payments across FL — which companies pay providers there.
